Clinical trials
Completed Phase 1/2 Virus Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioNTech SE | 2 |
| ModernaTX, Inc. | 2 |
| National Center for Research Resources (NCRR) | 2 |
| AlloVir | 1 |
| Banc de Sang i Teixits | 1 |
| Biolex Therapeutics, Inc. | 1 |
| Cytheris SA | 1 |
| Federal University of Minas Gerais | 1 |
| Genelux Corporation | 1 |
| Immune Targeting Systems Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 20 |
| COVID-19 | 5 |
| Influenza, Human | 5 |
| Coronavirus Infections | 4 |
| RNA Virus Infections | 4 |
| Communicable Diseases | 3 |
| Immune System Diseases | 3 |
| Respiratory Tract Infections | 3 |
| Epstein-Barr Virus Infections | 2 |
| Hepatitis C | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.